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Although a great deal of information is known about Post Traumatic Stress Disorder 
(PTSD), potential physiological risk factors for PTSD development are still unclear. Further, 
there are few prospective studies conducted with PTSD. One potential risk factor for the 
development of PTSD is an individual’s cardiovascular reactivity and recovery in response to 
stressor tasks. The current study was conducted with 763 Army National Guard and Army 
Reserve soldiers. Participants completed a stressful induction along with self-report measures 
prior to deployment. Post-deployment, self-report measures were completed to assess PTSD 
symptomatology and experiences related to deployment and combat. Multiple regression was 
used to determine the ability of blood pressure response to stress induction to predict PTSD 
symptoms immediately and one-year post-deployment. Results indicated that soldiers who had a 
less reactive systolic blood pressure  response to stressor tasks reported more PTSD 
symptomatology immediately after and one year after deployment. Furthermore, slower blood 





immediately and one year post-deployment. These results suggest the possibility that soldiers 



















The Effect of Pre-Deployment Physiology as a Predictor of Post-Traumatic Stress Disorder 
Among a Sample of United States Army National Guard and Reserve Soldiers 
 
Within the United States, Post-Traumatic Stress Disorder (PTSD) continues to be a 
prominent public health issue. According to Kessler et al. (2005) the lifetime prevalence rate for 
PTSD is 6.8% within a community population. Further, 3.5% of individuals report PTSD in the 
past year (Kessler et al., 2005). Among soldiers, recent estimates indicate a 13.8% prevalence 
rate of PTSD among OIF/OEF/OND veterans (Tanielian & Jaycox, 2008). More specifically, 
twelve months after deployment, 16.6% to 30.5% met symptom level criteria for PTSD (Thomas 
et al., 2010). Thus, PTSD is an especially important public health issue among Veterans.  
Because PTSD is associated with a distinct, potentially traumatic event, a unique 
opportunity exists for prevention. Unlike many other disorders in the DSM, a diagnosis of PTSD 
requires a significant and life threatening event. This creates a set of discrete periods where 
prevention can occur, both prior to, and after the occurrence of, a potentially traumatic event. 
With this in mind, prevention can be separated into three categories as proposed by Caplan & 
Grunebaum (1967): primary prevention (before the development of a disorder), secondary 
prevention (treatment once a disorder exists), and tertiary prevention (increasing functioning 
once a disorder has remitted). Within PTSD, the primary focus has centered on secondary and 
tertiary prevention efforts. Secondary prevention efforts have focused on treatments that promote 
symptom remission in PTSD (Foa, Rothbaum, Riggs, Murdock, 1991; Resick & Schnicke, 1992; 
Monson, Schnurr, Resick, Friedman, Young-Xu, Stevens, 2006; Tuerk et al., 2011). Recent 
literature has found that treatment of symptoms is only effective for a proportion of the 
population (Bradley, Greene, Russ, Dutra, & Westen, 2005; Imel, Laska, Jakupcak, & Simpson 
2013). Despite a reduction of symptoms, increased vocational productivity, maintenance of 





Litz, 2013; Adler et al. 2015). Although widespread secondary and tertiary prevention efforts 
have occurred (Foa, Rothbaum, Riggs, Murdock, 1991; Resick & Schnicke, 1992; Goldberg & 
Resnick, 2010; Karlin & Cross, 2013), many individuals still suffer from symptoms of PTSD and 
reduced quality of life (Steenkamp & Litz. 2013). These treatment efforts and continued tertiary 
consequences have a substantial impact on society. According to Tanelian & Jaycox (2008) 
PTSD among soldiers has an estimated societal cost (e.g., lost production, missed work days) of 
1.2 billion dollars each year. Further, when compared to other anxiety disorders in the general 
population, PTSD is associated with the greatest number of lost work days (Kessler & 
Greenberg, 2002). Based on lack of efficacy associated with treatment, number of lost work 
days, and continued suffering of individuals with PTSD, there is a need for more primary 
prevention efforts.  
In this paper, I will first review the relatively limited existing literature on primary 
prevention in PTSD. Due to the limits of the secondary data analysis that will be completed here, 
I will focus the literature review specifically on potential personality and psychophysiological 
pre-trauma risk factors for PTSD. These were selected as they were a focus of the larger study 
from which this study was derived. Based on the literature on potential personality and 
psychophysiological risk factors for PTSD, I will propose several hypotheses for the current 
study. Next, I provide an overview of a large prospective cohort study designed to assess 
potential pre-deployment factors that were hypothesized to be associated with negative post-
deployment mental and physical health outcomes. This study focused on a group of high-risk 
individuals, Army National Guard and Reserve soldiers, whom previous research has found to be 
at an increased risk of developing PTSD when compared to their active duty counterparts (Baker 





Vasterling et al. 2010). We will then describe the methods of the current secondary data analysis, 
focusing on blood pressure reactivity and recovery as predictors of PTSD symptoms and I will 
discuss results based on these secondary analyses. Finally I will discuss the theoretical and 


























If we hope to decrease the prevalence of PTSD, steps must be taken to prevent the 
disorder before the occurrence of a potentially traumatic event via primary prevention. Few 
studies have employed a prospective design to examine factors associated with the development 
of PTSD diagnosis and symptoms prior to a traumatic stressor. In a recent review, DiGangi, 
Gomez, Mendoza, Jason, Keys, & Koenen (2013) determined that specific pre-trauma risk 
factors, including cognitive abilities, poor coping, negative personality types, previous 
psychopathology, physiological arousal, and social and ecological factors are associated with the 
diagnosis and development of PTSD symptoms (DiGangi et al., 2013).  This review highlights 
that specific personality and biological factors are potential targets for primary prevention work. 
Of the factors reviewed in DiGangi et al. (2013) these factors were selected for use in this work 
because they were assessed as part of the larger parent study. 
Several pre-trauma personality factors have been suggested as important in the prediction 
of PTSD symptoms. Studies measuring personality factors prior to trauma have focused on 
negative affect (Bramsen, Dirkzwager, & van der Ploeg, 2000), neuroticism (van den Hout & 
Englehard, 2004; Knezevic, Opacic, Savic, & Priebe, 2005; Parslow, Jorm, & Christensen, 2006; 
Breslau & Schultz, 2013; Nielsen, Andersen, & Hogh, 2015), and trait anxiety/coping (McNally 
et al. 2011). Other studies have shown a relationship between pre-trauma personality 
characteristics including self-efficacy (Heinrichs et al. 2005), hostility (Ogle, Rubin, & Siegler) 
and trait dissociation (Hodgins, Creamer, & Bell, 2001). Of these factors, neuroticism has been 
especially important in predicting the development of PTSD symptoms and diagnosis across 
multiple samples including soldiers, the elderly, pregnant women, and the general population. 





personality is relatively stable (Costa & McCrae, 1986) and therefore, difficult to modify. 
Therefore, examination of biological factors, which are considered more modifiable (DiGangi et 
al. 2013) may be more useful in primary prevention efforts.  
Biological factors provide a unique opportunity for primary prevention as they have 
shown an ability to predict the development of PTSD. Among the important biological factors 
studied thus far are alterations in activity of the autonomic, endocrine, and immune systems. The 
autonomic nervous system is a major division of the peripheral nervous system that mediates the 
“fight or flight” response via the sympathetic nervous system and supports resting or basal 
functions via the parasympathetic nervous system (Robertson, Biaggioni, Burnstock, Low, & 
Paton, 2012). The endocrine system produces hormones responsible for a range of functions 
including arousal, sexual behavior, growth, and stress (Neal, 2016). The immune system is 
comprised of mechanisms that protect the body from external and internal threats (Parham, 
2015). Interventions that alter autonomic functioning have shown greater promise than those 
impacting immune and endocrine functioning.   There is a growing literature highlighting the 
ability to alter autonomic functioning through treatment efforts, including biofeedback (Del 
Pozo, Gevirtz, Scher, & Guarneri, 2004; Nolan et al. 2005; Ginsberg & Fogo, 2014) and 
pharmacologic agents (Kotler, Matar, & Kaplan, 2000; Vaiva et al. 2003). Further, autonomic 
changes soon after a potentially traumatic event have been shown to predict the later occurrence 
of a PTSD diagnosis. For example, research has found that increased autonomic arousal at rest, 
in reaction to trauma-oriented cues, and slower recovery from trauma cues occur in those with a 
diagnosis of PTSD (Blanchard, 1990; Buckley & Kaloupek, 2001; Pole, 2007). Studies focusing 
on the acute stress period have found that alterations in heart rate (HR) and blood pressure (BP), 





of PTSD at follow up (Shalev et al. 1998; Bryant, Harvey, Guthrie, and Moulds 2000; Bryant, et 
al., 2003; Bryant et al., 2008; Coronas, Gallardo, Moreno, Suarez, Garcia-Pares, and Menchon 
2011). These studies demonstrate that HR and BP reactivity soon after a potentially traumatic 
event confer an increased risk of developing PTSD and can be targets of intervention, and 
discriminative factors in diagnosis. Therefore, further exploration of HR and BP in the pre-
trauma phase can provide potential targets for primary prevention. 
Other studies have examined immune and endocrine functioning as other potentially 
important pre-trauma biological factors. In a series of studies measuring endocrine functioning, 
glucocorticoids have shown promise as a pre-trauma risk factor indicating who is more likely to 
develop PTSD among Dutch soldiers both immediately after and six months after deployment 
(van Zuiden, et al., 2009; van Zuiden, et al., 2011; van Zuiden et al., 2012a; van Zuiden et al., 
2012b). When measured prior to deployment among a group of U.S. military personnel, markers 
of immune functioning were predictive of an increased risk for PTSD diagnosis after deployment 
(Glatt et al., 2013; Eraly et al., 2014). Thus, studies of immune and endocrine functioning 
provide additional evidence of biological factors that may serve as biological precursors to 
PTSD. 
Measures of change in the autonomic nervous system and facial muscles have provided 
some of the most extensive evidence for potential prospective psychophysiological risk factors 
associated with the development of PTSD. In the first prospective study of its kind, Guthrie and 
Bryant (2006) examined firefighters during cadet training.  Their primary autonomic measure 
was skin conductance (SC), which reflects localized sympathetic activity to the sweat glands in 
the skin (Dawson, Schell, & Filion, 2007). In a conditioning experiment Guthrie & Bryant 





muscle region activity, which is involved in furrowing of the brow, see Larsen, Norris, & 
Cacioppo, 2003) was predictive of PTSD symptoms twenty-four months after beginning 
firefighting duties. They did not find that SC during a conditioning procedure prior to a 
potentially traumatic event was predictive of later PTSD symptomatology. These findings 
indicate that PTSD symptoms after exposure to a potentially traumatic event were not predicted 
by autonomic reactions to conditioning. In another study of pre-trauma autonomic functioning, 
Pole, Neylan, Otte, Henn-Hasse, Metzler, and Marmar (2009) examined the role of multiple 
autonomic variables as potential predictors of PTSD symptoms. The overall best baseline (pre 
vocational training) predictors of increased PTSD symptoms after serving as a police officer for 
twelve months were increased SC responses to loud tones in a high threat of shock condition 
(where shock was administered) and a return to baseline of SC after loud tones. Contrary to 
Guthrie & Bryant et al., (2006) Pole et al. (2009) demonstrated that increased SC reactivity and 
slowed recovery from conditioning prior to a trauma can be predictive of PTSD symptoms after 
experiencing a potentially traumatic event. In another prospective study, Orr, Lasko, Macklin, 
Pineles, Chang, and Pitman (2012) measured police and firefighter trainees both before a 
traumatic event and again after exposure to a potentially traumatic event.  Orr et al. (2012) found 
that increased SC responses to loud tones and greater HR reactivity during pre-trauma 
conditioning predicted greater post-trauma reactivity on the same measures when reading a script 
describing the potentially traumatic event. In addition, Orr et al. (2012) found that the only pre-
trauma biological factor associated with having more self-reported PTSD symptoms after 
exposure to a traumatic event was Corrugator EMG during a conditioning procedure prior to 
beginning vocational training.  The findings of Orr et al. (2012) show that increased autonomic 





to a traumatic script after a potentially traumatic event but not self-reported PTSD symptoms. 
Finally, in a prospective study, Minassian et al. (2015) examined autonomic functioning within a 
sample of United States Marines. Minassian et al. (2015) found that lower resting heart rate 
variability (HRV) was associated with PTSD diagnosis 6-months after return from deployment. 
Although prior studies found autonomic predictors related to PTSD symptoms, Minassian et al. 
(2015) is the first to find an autonomic measure as predictive of a diagnosis of PTSD. Moreover, 
their finding was within a group of active duty marines, providing the first prospective study of 
active duty personnel and autonomic functioning.  
When considered together, these studies offer a murky picture of pre-trauma autonomic 
physiology as a predictor of PTSD symptoms and diagnosis. The most frequently studied 
measure, SC, reveals a mixed picture as only Pole et al. (2009) found that SC reactivity and 
slowed recovery was associated with PTSD symptoms, while Guthrie & Bryant (2006) and Orr 
et al. (2012) reported non-significant results related to PTSD symptoms. In addition, Orr et al. 
(2012) found that pre-trauma SC was predictive of acute post-trauma HR, SC, and EMG but not 
self-reported PTSD symptoms. These findings though are difficult to interpret, as they only show 
a change in autonomic and skeletal muscle reactivity but are not associated with increased PTSD 
symptoms.  Furthermore, the prospective studies discussed here suggest that HR was not 
associated with self-reported PTSD symptoms (Pole et al. 2009) but was predictive of acute post-
trauma HR, SC, and EMG when reading a traumatic script (Orr et al. 2012). In contrast to other 
autonomic measures, HRV was associated with later PTSD diagnosis when measured at rest 
(Minassian et al., 2015). This finding, unlike those with SC and HR is the first to demonstrate 
that a cardiovascular variable can prospectively predict a diagnosis of PTSD. Importantly, most 





low levels of PTSD, with only one individual meeting criteria for possible PTSD. Therefore, 
these findings may not provide strong evidence of which psychophysiological factors are most 
likely to predict later occurrence of PTSD or distressing PTSD symptoms. Therefore, continued 
research is needed to help further delineate the potential utility of autonomic reactivity as a 
potential predictive factor for later PTSD symptoms or diagnosis.  
The current study will examine the link between BP reactivity and recovery to stressors 
during the pre-trauma period as a potential susceptibility factor for developing PTSD symptoms 
after a traumatic experience. I had intended to include personality variables in the current model 
as well but was unable to because of limitations of data access during the writing of this thesis. 
The current study will examine a group of Army National Guard and Reserve soldiers (NGR), 
who are an ‘at risk’ population for developing PTSD (Vasterling et al. 2010). During the pre-
trauma period, NGR soldiers participated in a series of heterogeneous stress tasks that were 
designed to create changes in autonomic functioning. The stressful tasks included a confrontation 
speech task, a planning task for the confrontation task, and a subtraction task during which 
cardiovascular functioning was measured. Participants’ cardiovascular functioning was also 
assessed while completing questionnaires and during a resting baseline.  The design of the 
overall study uniquely positions the current secondary data analysis to assess the ability of blood 
pressure reactivity and recovery to predict later PTSD symptoms. Therefore, based on the related 
literature highlighted above, we hypothesize the following results in the current study. 
Hypotheses 
Hypothesis 1: Those National Guard and Reserve Soldiers who react to stressful tasks 
with a larger increase in blood pressure (BP), will be more likely to develop PTSD symptoms 





Hypothesis 2: Those National Guard and Reserve Soldiers who have a smaller decrease 
in BP following stressful tasks will be more likely to develop PTSD symptoms immediately post 
deployment and one-year post deployment 
Hypothesis 3: The effects of BP reactivity and recovery as predictors of PTSD symptoms 





The data used in the current study are from a larger study designed to assess soldiers’ pre-
deployment psychosocial and physiological predictors of physical symptoms, self-reported 
physical and mental health function, and health care utilization rates (McAndrew, D’Andrea, Lu, 
Abbi, Yan, Engel, & Quigley, 2013; McAndrew, Helmer, Phillips, Chandler, Ray, & Quigley, 
2016; Quigley et al., 2012; Yan, et al. 2012). Collection of data occurred between November 
2005 and January 2011. Data were collected at four phases: pre-deployment, immediately post 
deployment, three months after return from deployment, and one-year post deployment.  
The current study used a prospective longitudinal cohort design. Inclusion criteria for the 
study were a pre-deployment age of 18 to 60 years, a resting BP below 140/90 at pre-
deployment, and being within the final states of preparation before deployment.  Exclusion 
criteria were assessed before deployment and included: current officer status; self-reported 
depression, schizophrenia, or bipolar disorder, and current pregnancy. Additionally, individuals 
were excluded from the study if they reported taking medications for heart or respiratory 
conditions, benzodiazepines, anti-depressants (at higher doses than used for depression), 





A total of 805 Army National Guard and Reserve soldiers were recruited prior to 
deployment from two bases, Fort Dix, New Jersey or Camp Shelby, Mississippi. Of those who 
were recruited, 795 initially consented to participation. From these 795 soldiers, 32 were 
officers, killed in action, or did not mobilize to a combat zone and therefore were excluded from 
analyses. In addition, four were excluded from analyses as they were hypertensive pre-
deployment. Thus, 763 soldiers were included in the final pre-deployment analyses. To assess for 
differences between those who volunteered for the study and those who did not, individuals who 
declined to participate (n = 410) anonymously reported their health status. A significant 
difference was found between the two groups on health status (72.1% of the participant sample 
vs. 78.8% of the non-respondent sample reported excellent/very good health; X2 = 8.25, p <0.01; 
McAndrew et al. 2016).  The number of participants at each phase included: pre-deployment 
(Phase 1; N=763), immediately post deployment (Phase 2; N=422), three months post-
deployment (Phase 3; N=286), and one-year post deployment (Phase 4; N=336). Deployment to 
warzones typically lasted 12-13 months for soldiers included in the study.  Immediate post-
deployment data were, in most cases, collected when participants returned to their bases. 
However, some soldiers returned to bases different than their original deployment base (Fort Dix 
or Camp Shelby). For soldiers who returned to different bases, questionnaires were mailed to 
their home address, however, we had no way to verify receipt of the questionnaires. As a result, 
we 303 soldiers to follow-up at Phase 2, while another 23 soldiers explicitly declined to 
participate at this phase. Three-month and one-year post deployment data were collected through 
mailed questionnaire packets. At three months after return from deployment, an additional 45 
participants declined to participate, and at one-year after return, another 50 participants declined 





Prior to deployment and immediately after deployment participants were not permitted by 
Department of Defense policy to receive compensation because of their active duty status. Once 
no longer on active duty, soldiers who participated at three months and one-year after return 
from post deployment were compensated $30 and $45, respectively.   
Immediately post deployment, participants who returned to Fort Dix or Camp Shelby 
completed questionnaires while on site. As indicated above, since many individuals returned to 
different bases, they were mailed questionnaires. Three-months and one-year post deployment, 
all soldiers who had not officially withdrawn consent to participate were mailed questionnaires.  
No physiological measurement was conducted at any time point after deployment.     
Procedures 
 Soldiers were approached by study staff and asked to volunteer while waiting for, or after 
completion of, their pre-deployment medical processing. Groups of soldiers were given a verbal 
briefing about the study. Among those interested, a second in-person verbal briefing occurred in 
the testing space, at which time those interested signed an informed consent document from the 
Department of Defense (approved by the Walter Reed Department of Clinical Investigation) and 
for the Department of Veterans Affairs (approved by the VA New Jersey Healthcare System and 
the G.V Montgomery VA Medical Center). Soldiers were provided with the appropriate referral 
services if they endorsed questions that indicated severe anxiety or depression.  
See Figure 1 for a detailed outline of timing for each task and flow of tasks for the pre-
deployment phase. During the pre-deployment assessment, participants first completed a set of 
questionnaires on a computer for 20-30 minutes. Next, participants were asked to complete the 
stressor tasks while psychophysiological measures were recorded. This assessment included a 
pre-task resting baseline (five minutes), stressor tasks (14 minutes), an initial post-task baseline 





after questionnaires were completed (5 minutes). All baselines were completed while the 
participant sat still in a quiet room. After the pre-task baseline, task instructions began. The first 
task induction included four minutes of planning out what they would say to another soldier in 
their unit whom they were to pretend someone had stolen $500 from them, and that they had to 
confront the person about the theft. Participants were then asked to deliver their confrontation by 
speaking into a microphone in front of a computer monitor as if speaking to the guilty person for 
four minutes.  They were also given several points to cover as part of what they said. After 
completion of the confrontation task, the soldier was asked to count backwards from a random 
four-digit number by sevens for four minutes. During this task, they were informed when they 
were incorrect, and if so, were asked to begin again with the last correct answer given. Finally, 
for up to two minutes, participants were asked to complete a hand cold pressor task in which they 
placed their hand in icy cold water. Physiological measurements were taken throughout the 
protocol with no pauses or breaks between tasks. Blood pressure and heart rate was measured 
using an automated monitor (GE DASH 2000) electronic arterial blood pressure cuff which 
compressed each minute.  
After completion of these tasks the participant started a recovery period in which s/he 
completed questionnaires. At the completion of this period, participants began the post-task 
resting baseline period. These two periods comprise the physiological recovery portion of 
measurement in the current study.   
Measures 
An appendix contains all items for all self-report measures used for the study. 
Blood Pressure and Heart Rate: Both BP and HR were collected using the DASH 2000 
meter by General Electric (Jupiter, FL). This is an automated oscillometric device, which was set 





assistant from the monitor display. Additionally, the hand written readings were double-checked 
against the memory of the device and after the check, results were cleared for each participant.  
Both systolic and diastolic BP reactivity and recovery measures were obtained as follows. 
Reactivity variables were computed by subtracting the mean of the baseline BP from the mean of 
the speech planning, speech delivery, and subtraction tasks. To derive the recovery with 
questionnaires variable we subtracted the mean BP of the post-task resting questionnaire period’s 
BP from the speech planning, speech delivery, and subtraction tasks. Finally, recovery without 
questionnaires was computed by subtracting the mean BP from the post task resting baseline 
from the mean BP of speech planning, speech delivery, and subtraction tasks.  
PTSD Symptoms. The 17-item PTSD Checklist (PCL-M; Weathers, Litz, Herman, 
Huska & Keane, 1993) assesses the presence and frequency of PTSD symptoms over the past 
month related to the individual’s military experience.  Participants respond on a 5-point scale 
from not at all bothered to extremely bothered (Weathers, et al., 1993). The questions on the 
PCL-M directly assess the seventeen symptoms of PTSD outlined in the Diagnostic and 
Statistical Manual – Fourth Edition (DSM-IV). Scores on the PCL-M range from 17-85. Higher 
summed scores indicate higher levels of PTSD symptomatology. Moreover, among military 
personnel, a cut off score of 50 has been established as a reasonable score for discriminating 
those with and without likely PTSD (McDonald & Calhoun, 2010). The PCL-M has shown 
excellent internal consistency and test-retest reliability (Blanchard, Jones-Alexander, Buckley, & 
Forneris, 1996). Additionally, scores on this measure correlate with the Clinician Administered 
PTSD scale (Blanchard et al., 1996), the gold standard of PTSD diagnostic measures. In the 





Deployment Risk and Resilience Inventory: The Deployment Risk and Resilience 
Inventory (DRRI: King, King, Vogt, Knight, & Samper, 2006) is a collection of measures 
designed to assess psychosocial risk and resilience factors associated with military personnel and 
deployment to war zones or other hazardous environments. The DRRI is composed of into 
fourteen constructs. Of these, the following were included in the study: pre-deployment life 
events (prior stressors and childhood family environment) combat experiences, and deployment 
related factors. On the pre-deployment life events and deployment related experiences 
questionnaire participants respond to questions with “Yes” or “No” responses to queries about 
events they may have experienced. On questions related to combat experiences participants were 
asked to respond on a 5-point scale ranging from never experienced to daily or almost daily. 
Higher scores on both measures indicate greater exposure to events that may put individuals at 
greater risk for multiple negative outcomes (King et al., 2006). Follow-up studies have shown 
good criterion validity for the DRRI on veterans from Operation Iraqi Freedom and Operation 
Enduring Freedom (Vogt, Proctor, King, King, Vasterling, 2008).  We found good reliability for 
these measures in the current study (Cronbach’s alphas: Pre-deployment life events: 0.77, 
Combat experiences: 0.90, Aftermath of Battle: 0.86).  
Analytic Plan 
 
To evaluate the relationship between blood pressure and the development of PTSD 
symptoms immediately after deployment and one-year after return from deployment, we used 
hierarchical and stepwise regression analyses. To test hypothesis one, that individuals who 
respond to stressor tasks with increased blood pressure would develop a greater number of PTSD 
symptoms immediately post deployment and at one-year post deployment, two simultaneous 





used as covariates as both may impact blood pressure. In the second step, SBP and DBP 
reactivity scores were added to assess for their unique contribution to predicting PTSD 
symptoms. Two separate regressions were conducted, one to predict the PCL-M total score 
immediately after deployment and one to predict the PCL-M at one-year after return from 
deployment.  
To test hypothesis two, that individuals who exhibited a smaller decrease in BP after 
stressful tasks would show more PTSD symptoms immediately post deployment and at one-year 
post deployment, four simultaneous multiple regression analyses were used. In the first step, both 
gender and BMI were used as covariates. In the second step, SBP and DBP recovery scores were 
added as predictors. Two separate regressions were conducted, one to assess their contributions 
to the prediction of the PCL-M total score immediately after deployment, and to assess their 
contributions to the prediction of the PCL-M total score one-year after return from deployment. 
These two regressions described above were each conducted twice with the first pair of 
regressions conducted with SBP and DBP recovery post task baseline entered as the IV. In the 
second pair of analyses, SBP and DBP resting post task baseline were entered as the IV.  
To test hypothesis three, that pre-deployment physiological responses will predict post 
deployment PTSD symptoms over and above the effects of pre-deployment life events, combat 
exposure, and deployment exposure, we conducted stepwise regressions. Gender and BMI were 
entered in the first step, pre-task baseline SBP and DBP were entered in the second step to 
control for pre-task differences in blood pressure, pre-deployment life events, combat exposure, 
and deployment exposure were entered in the third step, and both SBP and DBP reactivity and 





For the current study, analyses were only conducted using blood pressure because of 
limitations due to data access imposed by the East Orange Veterans Affairs Medical Center. 
Thus, analyses using heart rate data were unable to be conducted. These issues were unrelated to 
the current data and the proposed analyses. As a result, the current thesis does not propose any 
analyses using heart rate and instead focuses solely on blood pressure. For information of the 
demographic make-up of the sample, refer to Table 3.  
Results 
Correlations 
 Means and standard deviations of all study variables, as well as bivariate correlations 





Table 1: Correlation Matrix of Study Variables: Immediate post deployment 
 
 1.  2.  3.  4. 5.  6.  7.  8.  9. 10.  11.  12.  M(SD) 
1. PTSD 
Symptoms  
-- -.004 -.02 -.003 -.08 .21** .28** .34** -.18* -.08 -.12* -.10 30.44 
(11.76) 
2. Gender  -- -.13* -.23** -.01 .01 -.16* -.14* -.07 -.05 -.09 .03 .09 (.28) 
3. BMI  -.13 -- .26** .21** .07 .05 .07 -.19* -.17* -.19* -.21** 27.79 
(5.10) 
4. Pre Task 
SBP 
 -.23** .26** -- .65** .07 .06 .08 -.01 -.12* .10 .04 113.39 
(11.21) 
5. Pre Task 
DBP 














Correlation Matrix of Study Variables: Immediate post deployment 
**Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 































Table 2: Correlation Matrix of Study Variables: One-year post deployment 
 1.  2. 3.  4.  5.  6.  7.  8.  9. 10.  11.  12.  M(SD) 
1. PCL_M_P4 -- -.02 .09* .01 .04 .25** .40** .41** -.16* -.09* -.12* -.09* 32.75 
(14.37) 
2. Gender -.02 -- -.2* -
.34** 
-.15* -.04 -.19* -.16* -.09* -.09* -.09* -.04 .09 (.28) 
3. BMI .09* -.20** -- .24** .21** .03 .19* .11* -.12* -.08 -.11* -.08 27.79 (5.10) 
4. Pre Task SBP .01 -.34** .24** -- .66* .01 .06 .06 .05 -.04 .17* .13* 113.39 
(11.21) 
5. Pre Task DBP .04 -.15* .21** .66** -- .12* -.004 -.001 -.02 -
.23** 
.03 -.06 61.83 (8.98) 
6. Pre-Deployment .25** -.04 .03 .01 .12* -- .21** .19* -.04 -.09* -.08 -.13* 5.77 (3.55) 





Correlation Matrix of Study Variables: One-year post deployment 
**Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
Note: Gender coded 0 = male, 1 = female
8. Deployment 
Exposure 
.41** -.16* .11* .06 -.001 .19* .71** -- -.12* -.05 -.04 -.02 4.15 (3.86) 
9. SBP React -.16* -.09* -.12* .05 -.02 -.04 -.08 -.12* -- .70** .80** .65** 12.17 (8.21) 
10. DBP React -.09* -.09* -.08 -.04 -.23** -.09* -.06 -.05 .70** -- .55** .72** 7.43 (5.17) 
11. SBP Recover -.12* -.09* -.11* .17* .03 -.08 -.04 -.04 .80** .55** -- .72** 7.14 (6.75) 





Hypothesis 1: Those National Guard and Reserve Soldiers who react to stressful tasks 
with a larger increase in blood pressure (BP), will be more likely to develop PTSD symptoms 
both immediately after deployment and one-year after return from deployment. 
Mean SBP and DBP for each minute of the study are depicted in Figure 1 and 2.  To test 
Hypothesis 1, two hierarchical regression models were run, one for immediate post deployment 
and one for one-year post deployment. Gender and body mass index (BMI) were entered into the 
first step of the regression, and SBP and DBP reactivity were entered into the model in the 
second step. The overall model significantly predicted PTSD symptoms immediately after 
deployment, F(4, 413) = 4.22, p <.001, R2 = .041,  and this model predicted PTSD symptoms 
better than gender and BMI alone, ∆R2 = .02, p <.001 (see Table 4 Appendix B for the complete 
regression results). Of the individual variables entered into the model, only lower SBP reactivity 
emerged as a significant predictor of PTSD symptoms immediately post deployment, t(415) = - 
3.55, 𝛽 = -.24, p < .001.  
To test this same hypothesis at one-year after deployment, the same predictors were 
entered into the model, and this time PTSD symptoms at one-year after deployment was the 
outcome variable. The overall model significantly predicted PTSD symptoms immediately after 
deployment F (4, 315) = 2.68, p = .03, R2 = .02, and was a significantly better model than gender 
and BMI alone, ∆R2 = .02, p =.02 (see Table 5 in Appendix B for the full regression results). 
Similar to the previous model, the only significant predictor that emerged was lower SBP 
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Figure 2: Mean DBP for each minute of the study 
 Resting Baseline          Speech Task       Speech Task    Subtraction Task    Cold Presser       Post Task             Recovery  
                                         Planning              Speaking                                                                        Questionnaire              without Q's      





Hypothesis 2:  Those National Guard and Reserve Soldiers who have a smaller decrease 
in BP following stressful tasks will be more likely to develop PTSD symptoms immediately post 
deployment and one-year post deployment 
To test the second hypothesis, two pairs of hierarchical regression models were run; one 
pair predicting immediate post deployment PTSD symptoms and one-year post deployment 
PTSD symptoms using SBP and DBP recovery as measured during the post-task questionnaire 
baseline, and the other pair of regression models predicting immediate post deployment PTSD 
symptoms and one-year post deployment PTSD symptoms using SBP and DBP recovery during 
the resting baseline that followed the questionnaires.  In the first step of each model, gender and 
BMI were entered. In the second step SBP and DBP recovery were entered into the model.  
The first regression used as a predictor the recovery during the post-task questionnaire 
baseline with the outcome of PTSD symptoms immediately after deployment. The overall model, 
with all predictor variables entered, significantly predicted PTSD symptoms F (4, 412) = 4.56, p. 
= 001, , R2 = .03, and predicted significantly better than did gender and BMI alone, ∆R2 = .04, p 
< .001 (see Table 6 in Appendix B for the full regression results). The only significant predictor 
of PTSD symptoms immediately after deployment was reduced SBP recovery during the post-
task questionnaire baseline t (414) = -2.58, 𝛽 =-.16, p =.01. Another model was used to assess 
the effect of recovery during the post task resting baseline. This model was significant F (4, 410) 
= 2.61, p. = .04 and accounted for 1.5% of the variance (see Table 7 in Appendix B for the full 
regression results). Despite a significant overall model, no individual predictors were significant.  
Two additional regression models were run, this time with PTSD symptoms at one-year 
after deployment as the outcome variable. The overall model with all predictors and using 





symptoms one-year post deployment, F (4, 314) = 2.15, p = .08 and was not a significantly better 
model than BMI and gender alone ∆R2 = .02, p =.065 (see Table 8 in Appendix B for the full 
regression results). Furthermore, none of the individual predictors in the model were significant. 
Of note, DBP recovery while completing questionnaires approached significance as a predictor 
of PTSD symptoms, t(317) = -1.94, 𝛽 = -. 14., p =.053, R2 = .03. The second regression using 
recovery during the post-task resting baseline was also not significant, F (4, 311) = 1.64, p = .17 
(see Table 9 in Appendix B for the full regression results). These results indicate that recovery 
from tasks only predicted PTSD symptoms immediately after deployment and not at one-year 
after deployment.  
Hypothesis 3: The effects of BP reactivity and recovery as predictors of PTSD symptoms 
will hold true over and above the effects of pre-deployment life events, combat exposure, and 
deployment exposure. 
Two stepwise regressions were conducted to determine the optimal model for predicting 
of PTSD symptoms immediately after deployment. In the first step, gender and BMI were 
entered. In the second step basal SBP and DBP (from prior to beginning the stressor tasks) were 
entered into the model to control for basal blood pressure. In the third step, the DRRI pre-
deployment life events, deployment exposure, and combat exposure were entered into the model. 
Finally, SBP and DBP reactivity and recovery were entered into the model in the fourth step. All 
variables were entered using a stepwise procedure. In the first model, SBP recovery during the 
post task questionnaire baseline was used, while in the second model, recovery during the post 
task resting baseline was used. This stepwise regression model found that three variables 
significantly predicted PTSD symptoms immediately after deployment, F (3, 331) = 20.06, p < 





deployment exposures, t (334) = 5.66, 𝛽 = .29, p <.001, and less SBP recovery during the post-
task questionnaire baseline t (334) = -2.913, 𝛽 = -.15, p =.004 predicted PTSD symptoms 
immediately after deployment (see Table 10 in Appendix B). This model predicted 15% of the 
variance in PTSD symptoms immediately after deployment. In a second analysis, when SBP 
recovery during the post-task resting baseline was used together with SBP reactivity, lower SBP 
reactivity t (329) = -2.91, 𝛽 = -.14, p =.01 emerged as a significant predictor along with pre-
deployment life events t (329) = 2.57, 𝛽 = .14, p =.01 and deployment exposures, t (329) = 5.66, 
𝛽 = -.29, p <.01 whereas SBP recovery was no longer a significant predictor (see Table 11 in 
Appendix B for the full regression results).  
 Two additional stepwise regression analyses were conducted to assess predictors of 
PTSD symptoms at one-year after deployment. The stepwise model significantly predicted PTSD 
symptoms, F (4, 318) = 22.56, p < .001. Similar to the model immediately after deployment, 
both pre-deployment life events t (317) = 2.98, 𝛽 = .15, p =.003 and deployment exposures, t 
(317) = 3.11, 𝛽 = .22, p =.002, emerged as significant predictors. In addition, combat exposure 
emerged as a significant predictor of PTSD symptoms at one-year after deployment, t (317) 
=2.82, 𝛽 = .20, p =.01. Finally, reduced SBP reactivity was a significant predictor regardless of 
which recovery variable was used in the model, t (317) = -2.26, 𝛽 = -.11, p =.03. The overall 
model predicted 21.3% of the variance in PTSD symptoms at one-year post deployment (see 
Table 12 and 13 in Appendix B). 
Discussion 
The purpose of the current study was to examine the relationship between pre-
deployment blood pressure reactivity and recovery to stressful tasks and post- deployment PTSD 





PTSD symptoms immediately after and one-year after deployment. Less SBP recovery during a 
post-task questionnaire baseline that immediately followed the stressor tasks was found to be the 
best predictor of PTSD symptoms immediately after deployment, but blood pressure recovery 
did not predict PTSD symptoms one-year after deployment. I also used a stepwise regression 
model to determine the best blood pressure reactivity and recovery predictors of post-deployment 
PTSD symptoms when controlling for exposure to trauma. Lower SBP recovery during a post-
task questionnaire baseline was the best predictor of immediate post-deployment PTSD 
symptoms, whereas less SBP reactivity better predicted PTSD at one-year after deployment. The 
final model derived using a stepwise procedure found that pre-deployment life events, 
deployment exposure, and reduced SBP recovery (while completing questionnaires) accounted 
for 15% of the variance in PTSD symptoms immediately after deployment.  Therefore, the best 
predictors of PTSD symptoms immediately after deployment were exposure to traumatic events 
and reduced SBP recovery during a post task questionnaire baseline.  Pre-deployment life events, 
deployment exposures, combat exposures, and reduced SBP reactivity to tasks significantly 
predicted PTSD symptoms at one-year after deployment. This model accounted for 21.3% of the 
variance in PTSD symptoms at one year after deployment.  Therefore, the best predictors of 
PTSD symptoms at one year after deployment were exposure to traumatic events and less SBP 
reactivity to the pre-deployment stressor tasks. 
The current study found that soldiers who responded to pre-deployment stressor tasks 
with lower SBP reactivity to and less SBP recovery from stressors prior to deployment were 
more likely to report increased PTSD symptoms after deployment. Unlike previous research 
using autonomic measures of PTSD, here a less reactive profile was predictive of later PTSD. To 





diagnosed with PTSD and exposed to multiple traumatic events (McTeague, et al. 2010). In this 
work, individuals who had experienced multiple traumas responded with a blunted 
cardiovascular response to imagery of their trauma compared to those exposed to a single event 
that led to PTSD. McTeague et al. (2010) hypothesized that this was due to a decrease in 
defensive reactivity; that individuals who had experienced multiple traumas no longer saw 
threats in the same manner as individuals with less trauma exposure.  These results are consistent 
with findings that individuals with more severe symptoms across a spectrum of anxiety disorders 
exhibit blunted responses when confronted with anxiety imagery (Lang & McTeague, 2009).  
Although Lang and McTeague (2009) interpret this blunted response as indicating that “normal 
defensive reactivity may be compromised by an experience of long-term stress” (p. 5), it may be 
the case that the tendency for blunted responding to stressors predates anxiety disorder 
symptoms.  In fact, the blunted responses associated with more severe anxiety disorders may be 
associated with a broader range of difficulties, including perhaps poorer  emotion regulation 
abilities that may be, in part, a cause of their later-developing anxiety symptoms. According to 
Gross (2013), emotion regulation is the capacity of an individual to respond with an appropriate 
emotion that is of suitable intensity and duration to a situation. Notably, previous research has 
found alterations in physiological responses among those with decreased emotion regulation 
(Gross, 2002). In line with the findings of McTeague et al. (2010), I suggest that a blunted 
physiological response to, and less recovering from, stressors, as found in the current study, may 
represent a deficit in emotion regulation. Specifically, those people who have trouble regulating 
emotional responses to stressors also may have greater difficulty regulating their responses to, 
and recovering from, deployment-related traumatic experiences. Further, deficits in emotion 





Boden, et al. 2013).  What I highlight here is the possibility that emotion regulation deficits pre-
date the occurrence of PTSD.    
A recent study highlighted the relationship between emotion regulation and blood 
pressure reactivity to stress (Delgado, Vila, & Reyes del Paso, 2014). Delgado et al. (2014) 
found, among a sample of high and low trait worriers (top and bottom 20% on a measure of 
worry), that higher trait worriers reacted to mental and auditory stressors with smaller magnitude 
BP responses than those lower in trait worry. Based upon these findings, Delgado et al. (2014) 
posited that increases in BP are a mechanism that reduces emotional distress provoked by the 
current stressful tasks (McCubbin et al. 2011). In support of the current hypothesis, individuals 
who are high in worry often exhibit less ability to regulate emotions than those low in trait worry 
(Salters-Pedneault, Roemer, Tull, Rucker, & Mennin, 2006). Therefore, lower  BP reactivity to 
stressors prior to the experience of a potentially traumatic event could be associated with a 
decrease in the ability to regulate emotions, similar to those high in trait worry.  
Consistent with the findings of the current study, Minassian et al. (2015) found that lower 
pre-deployment HRV, an autonomic effect suggestive of less resting parasympathetic activity, 
was predictive of PTSD diagnosis six months later in a sample of marines. Lower HRV also has 
been associated with a reduced ability to regulate emotions (Thayer & Lane, 2000), and multiple 
studies have shown that increased emotion regulation is associated with increased basal HRV 
(Butler et al. 2006; Smith et al. 2011). These findings suggest that soldiers who exhibit lower 
basal HRV may be more likely to have poor emotion regulation abilities and be more likely to 
develop PTSD.  Further work that directly measures emotion regulation capabilities will be 







Based on the finding that PTSD is related not only to exposure to traumatic events but to 
reduced blood pressure reactivity to and recovery from stressors, and the speculation that this is 
related to reduce emotion regulation capacity, it suggests that one target for primary prevention 
may be alteration of physiological arousal. One way of altering an individual’s physiological 
reactivity and recovery from anxiety-producing situations is the use of biofeedback. Biofeedback 
is a method of altering physiological processes through conscious awareness of sensations by 
monitoring and providing input to the person about the physiological changes underlying those 
sensations (Schwartz & Andrasik, 2003). Multiple studies have found that biofeedback can be 
used, e.g., to increase HRV (Del Pozo, Gevirtz, Scher, & Guarneri, 2004; Nolan et al. 2005; 
Ginsberg & Fogo, 2014).  As detailed in Minassian et al. (2015), prior to deployment, decreased 
HRV was associated with an increased likelihood of developing PTSD. The current results 
suggest that reduced blood pressure reactivity and recovery to stressors is associated with greater 
risk of PTSD symptoms. Therefore, an intervention targeted at regulation of BP or HRV or other 
autonomically-related sensations may buffer the impact of a traumatic event. In support of this 
claim, Peira, Pourtois, & Fredrickson (2013) found that biofeedback could be used to increase a 
person’s ability to regulate his/her HR. Furthermore, in support of my speculation about the link 
between blunted blood pressure reactivity and recovery and reduced emotion regulation capacity, 
Peira et al. (2013) found that an increased ability to regulate HR was associated with an 
increased ability to regulate emotions to emotionally distressing situations. Participants were not 
only able to regulate their HR responses but were able to do so when presented with a stimulus 
they experienced as negative. Moreover, in a follow up study, individuals who had received 
biofeedback compared those who received sham biofeedback, were better able to regulate their 





evidence that biofeedback can help a person to better regulate their physiology when presented 
with negative stimuli. In addition to HR and HRV, multiple studies have also demonstrated 
efficacy of biofeedback for the regulation of blood pressure (Lin et al. 2012; Wang et al. 2010) 
Therefore, biofeedback may aid individuals in regulating multiple different kinds of autonomic 
functioning.  
The use of biofeedback among individuals with PTSD also has empirical support. In an 
early study of biofeedback among Vietnam veterans with PTSD, Hickling, Sison, & 
Vanderploeg, (1996) found that EMG biofeedback produced noticeable decreases in PTSD 
symptoms, specifically decreasing the heightened arousal associated with PTSD, when included 
as part of a cognitive behavioral therapy treatment regimen. Moreover, recent studies among 
OEF/OIF veterans have found significant decreases in number of individuals diagnosed with 
PTSD when HRV biofeedback is included in combination with Prolonged Exposure (PE), 
Cognitive Processing Therapy (CPT), or Acceptance and Commitment Therapy (ACT; Tan, 
Wang, & Ginsberg, 2013). According to Tan et al. (2013), decreases in arousal and increases in 
attention and memory were associated with an overall reduction in PTSD symptoms among 
patients using biofeedback treatment in conjunction with PE or CPT. A recent pilot study also 
noted that individuals who underwent trauma-focused CBT achieved symptom remission faster 
when using HRV biofeedback than those who did not (Polak, Witteveen, Denys, & Olff, 2015).  
Therefore, there is tentative support for the success of biofeedback as a treatment for individuals 
who have developed PTSD.  If, as suggested by the current study, biofeedback is helpful for 
people with PTSD because they begin to learn to better regulate their autonomically-mediated 





personnel in the regulation of their autonomic functioning, perhaps leading to an increased 
ability to regulate emotions as a buffer against the effects of traumatic experiences.  
Based upon the current findings, screening of autonomic functioning prior to deployment 
may help identify those vulnerable to developing PTSD.  Within the context of the current study, 
screening individuals in the National Guard/Reserve component of the military is indicated as 
they have higher rates of PTSD and develop PTSD at a higher rate than their active duty 
counterparts (Baker et al. 2009; Smith et al. 2009; Thomas, Wilk, Riviere, McGurk, Castro, & 
Hoge, 2010; Vasterling et al. 2010). Moreover, National Guard/Reserve soldiers who exhibit 
decreased SBP reactivity and recovery from tasks may then be more closely tracked to assess for 
signs of PTSD and enrolled in early interventions. Multiple studies have demonstrated efficacy 
for CBT, brief exposure therapy, beta adrenergic blockade and glucocorticoid administration 
during the acute stress period following a traumatic event (Kearns, Ressler, Zatzick, & 
Rothbaum, 2012;Vaiva, et al. 2003). These strategies, implemented prior to PTSD diagnosis, 
would be considered primary prevention, and could reduce the overall incidence of PTSD. By 
implementing primary prevention strategies such as biofeedback, enhanced surveillance, and 
possible pharmacological pre-treatment prior trauma exposure, we may be able to substantially 
reduce the incidence of PTSD.  
Limitations  
 
 The current study has a few noteworthy limitations. The findings of the current study are 
limited to blood pressure and thus do not capture the full scope of physiological reactivity and 
recovery to tasks. Other variables, including HR, HRV, SC, and corrugator EMG, may provide 
further clarification of the current findings, because prior research has linked increases in SC 





adding other biological measurements and measures of emotion regulation, a more specific 
emotion regulation capacity hypothesis can be developed. One variable that should receive 
significant attention is HR. Heart Rate has shown strong predictive ability in the acute stress 
phase across multiple studies (Shalev et al., 1998; Bryant et al., 2000; Bryant, Harvey, Guthrie, 
& Moulds, 2003; Bryant, Salmon, Sinclair, & Davidson, 2007; Bryant, Creamer, O’Donnell, 
Silove, & McFarlane, 2008; Suendermann, Ehlers, Boellinghaus, Gamer, Glucksman, 2010; 
Coronas, Gallardo, Moreno, Suarez, Garcia-Pares, & Menchon, 2011). Therefore, HR may be an 
especially sensitive predictive measure in studies where physiology can be measured prior to a 
trauma. Another limitation is that the current study’s stressor task design does not allow for 
determination of the unique contribution of different tasks as specific predictors of PTSD 
symptoms. As there were no rest periods between tasks, it is more difficult to isolate the 
autonomic responses during each task as a specific and unique predictor.  Thus, e.g., one cannot 
say whether it is the BP response to preparing for the confrontation task or to actually doing the 
confrontation task that is associated with PTSD symptoms, or whether a more generalized BP 
reactivity and recovery is most important. In addition, as soldiers completed questionnaires after 
completing the task period, we cannot disentangle whether the predictive usefulness of the SBP 
recovery is due to the timing of this period (i.e., it was the first five minutes of recovery) or could 
also be a function of simultaneously completing questionnaires. Additionally, because recovery 
was calculated as a reduction from task reactivity, lower recovery is confounded by less 
reactivity, as this would produce a restriction in the amount of blood pressure reduction needed 
to return to a resting baseline.  
 Another limitation of the study is that PTSD symptoms were not assessed prior to 





physiological reactivity already had more PTSD symptoms prior to deployment. As detailed 
above, McTeague et al. (2010) found that lower SBP reactivity to threatening imagery was 
associated with exposure to multiple traumatic events. Therefore lower SBP reactivity pre-
deployment could be a result of a prior trauma history and/or PTSD symptoms prior to 
deployment, rather than a de novo predictor of PTSD symptoms after deployment. Furthermore, 
inhibited physiological recovery from stressors is a hallmark of PTSD (Jovanovic & Ressler, 
2010) and without pre deployment measurement of PTSD symptoms, there is the possibility that 
individuals with blunted BP responses already had greater PTSD symptoms at the time of the 
pre-deployment assessment.  
Conclusions 
 Despite the aforementioned limitations, the current study contributes to the literature by 
showing that lower SBP reactivity to stressor tasks given prior to deployment is associated with 
more PTSD symptoms immediately after deployment and one-year after deployment. 
Furthermore, the current study also demonstrated that lower SBP recovery predicted PTSD 
symptoms immediately after deployment.  These effects were found in a sample of National 
Guard and Army Reserve soldiers, in whom multiple studies have shown higher rates of PTSD 
symptoms and diagnosis when compared to their active duty counterparts (Baker et al. 2009; 
Smith et al. 2009; Thomas, Wilk, Riviere, McGurk, Castro, & Hoge, 2010; Vasterling et al. 
2010). Furthermore, the current sample was comprised of individuals who reported substantially 
higher current PTSD symptoms compared to previous studies examining these issues using a 
prospective design (e.g. Guthrie & Bryant, 2006; Orr et al. 2012; Pole et al. 2009). Thus, the 
results of the current study are more representative of a population of individuals who are likely 
to be diagnosed with PTSD (similar to Minassian et al.; 2015). The current study is the first to 





PTSD symptoms, and further substantiates the literature that less BP recovery from stressor tasks 
is associated with more symptoms of PTSD (Guthrie & Bryant, 2006; Pole et al. 2009; Orr et al. 
2012). In doing so, the current study suggests feasible potential targets for primary prevention 
(i.e., BP biofeedback) prior to deployment for National Guard and Army Reserve soldiers in 























Table 3. Characteristics of Initial Sample. 
 Immediately Prior to Deployment  
Demographics 
Gender 
   Male 
   Female 
 
688 (89.7%) 
79  (10.3%) 
Age – mean years (SD) 28.0 (8.3) 
Range: 18 - 57 
Education  97.4% high school graduate. 
2.0%  Bachelors 
Military Component 
   National Guard 
   Reserve 






   White 
   Black 
   American Indian 
   Asian/Pacific Islander 
   Mixed race/Other 
 
592 (77.2%) 
69   (9.0%) 
21   (2.7%) 
21   (2.7%) 
48   (6.3%) 
Ethnicity 









Figure 3. Order of physiological measurement 
 
  Resting Baseline-5 Minutes 
Speech Task: Planning– 4 Minutes 
Speech Task: Speaking– 4 Minutes 
Subtraction Task– 4 Minutes 
Cold Presser– Up to 2 Minutes 
Recovery with Questionnaires– First 5 Minutes (total of 30 
minutes 
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Figure 5: DRRI-PDLE 
The statements below refer to events you may have experienced. Please circle “yes” or “no” for each 
item below. 
 I have experienced… 
      
1. ...a natural disaster (for example, a flood or hurricane), a fire, or    
           an accident in which I was hurt or my property was   
           damaged.   
Yes No 
  2.   ...exposure to a toxic substance (such as dangerous chemicals,    
           radiation).     
Yes No 
  3.   ...combat or exposure to a war zone (in the military or as a civilian).     Yes No 
  4.   ...the mental illness (for example, clinical depression, anxiety  
         disorder), or life-threatening physical illness (for example, cancer   
         or heart disease) of someone close to me.   
Yes No 
  5.   ...a parent who had a problem with drugs or alcohol.        Yes No 
  6.   ...the death of someone close to me.       Yes No 
 I have ... 
    
7. ...been through a divorce or been left by a partner or significant    
           other. 
  Yes No 
  8.   ...witnessed someone being assaulted or violently killed.   Yes No 
  9.   ...been robbed or had my home broken into.   Yes No 
110.   ...lost my job.   Yes No 
11.   ...been emotionally mistreated (for example, shamed, embarrassed, 
            ignored, or repeatedly told I was no good).   
Yes No 
12.   ...seen or heard physical fighting between my parents or caregivers.   Yes No 
13.   ...been physically punished by a parent or primary caregiver.    Yes No 
14.   ...been physically injured by another person (for example, hit, kicked,  
           beaten up).  
Yes No 





15.   ...experienced unwanted sexual activity as a result of force, threat of   
           harm, or manipulation.    
Yes No 



























Figure 6: DRRI-CE  
**The response options for the CE subscale were changed from a yes/no format to the following: 0 = 
never, 1 = a few times over the entire deployment, 2 = a few times each month, 3 = a few times each 
week, and 4 = daily or almost daily.  This was done to more sensitively measure exposure to critical 
events such as feeling in mortal danger, or anxiety about combat patrols or other missions.  The 
modified CE subscale was on a 0-60 scale. 
The statements below are about your combat experiences during deployment. Please circle “yes” if the 
statement is true or “no” if the statement is false. 
While deployed: 
      
  1.   I went on combat patrols or missions.   0  1  2 3 4  
  2.   I or members of my unit encountered land or water mines and/or booby traps.   0  1  2 3 4  
  3.   I or members of my unit received hostile incoming fire from small arms,   
        artillery, rockets, mortars, or bombs.   
0  1  2    3   4  
  4.   I or members of my unit received "friendly" incoming fire from small arms,  
        artillery, rockets, mortars, or bombs.   
0  1  2 3 4  
  5.   I was in a vehicle (for example, a truck, tank, APC, helicopter, plane, or boat)   
        that was under fire.      
0  1  2 3 4  
  6.   I or members of my unit were attacked by terrorists or civilians.   0  1  2 3 4  
  7.   I was part of a land or naval artillery unit that fired on the enemy.   0  1  2 3 4  
  8.   I was part of an assault on entrenched or fortified positions.   0  1  2 3 4  
  9.   I took part in an invasion that involved naval and/or land forces.   0  1  2 3 4  
10.   My unit engaged in battle in which it suffered casualties.   0  1  2 3 4  
11.   I personally witnessed someone from my unit or an ally unit being seriously  
        wounded or killed.   
0  1  2 3 4  
12.   I personally witnessed soldiers from enemy troops being seriously wounded or  
        killed.  





13.   I was wounded or injured in combat.   0  1  2   3    4  
14.   I fired my weapon at the enemy.   0  1  2 3 4  
15.   I killed or think I killed someone in combat.   0  1  2 3 4  
 

























Figure 7: DRRI-DE 
  1.   I observed homes or villages that had been destroyed.   Yes No 
  2.   I saw refugees who had lost their homes and belongings as a result of battle.   Yes No 
  3.   I saw people begging for food.   Yes No 
  4.   I or my unit took prisoners of war.   Yes No 
  5.   I interacted with enemy soldiers who were taken as prisoners of war.   Yes No 
  6.   I was exposed to the sight, sound, or smell of animals that had been wounded or  
        killed from war-related causes.   
Yes No 
  7.   I took care of injured or dying people.   Yes No 
  8.   I was involved in removing dead bodies after battle.   Yes No 
  9.   I was exposed to the sight, sound, or smell of dying men and women.   Yes No 
10.   I saw enemy soldiers after they had been severely wounded or disfigured in  
        combat.   
Yes No 
11.   I saw the bodies of dead enemy soldiers.   Yes No 
12.   I saw civilians after they had been severely wounded or disfigured.   Yes No 
13.   I saw the bodies of dead civilians. 
  Yes No 
14.   I saw Americans or allies after they had been severely wounded or disfigured in  
        combat.   
Yes No 










Appendix B: Summary of Regression Results 
 






t p R2 ∆R2 
Step 1 Model 
(Covariates) 
.12     .01  
Gender  .03 .001 .01 .99   
BMI  -.11 -.05 -.94 .35   
Step 2 Model 4.36**     .03 .02 
SBP Reactivity  -.34 -.24 -3.55** <.001   
DBP Reactivity  .12 .05 .81 .42   
DV = PCL-M (PTSD) Immediate Post Deployment 
*Significant at the 0.05 level 
**Significant at the 0.001 level 





t p R2 ∆R2 
Step 1 Model 
(Covariates) 
1.38     .002  
Gender  -1.33 -.03 -.53 .60   
BMI  .23 .07 1.18 .24   
Step 2 Model 2.68*     .02 .02 





DBP Reactivity  .04  .11 .47 .64 
DV = PCL-M (PTSD) one-year post deployment 
Summary of Hierarchical Regression Analysis: Hypothesis 2 






t p R2 ∆R2 
Step 1 Model 
(Covariates) 
.12     .004  
Gender  .72 .02 .35 .73   
BMI  -.12 -.05 -1.03 .30   








 -.17 .07 -1.09 .28   
DV = PCL-M (PTSD) Immediate Post Deployment 






t p R2 ∆R2 
Step 1 Model 
(Covariates) 
.12     .004  
Gender  .48 .01 .23 .82   





Step 2 Model 2.61     .02 .02* 
SBP Recovery 
(No distraction) 




 -.19 -.08 -1.23 .22   






t p R2 ∆R2 
Step 1 Model 
(Covariates) 
1.43    .24 .003  
Gender  -.59 -.01 -.23    
BMI  .22 .07 1.16    








 -.45 -.14 -1.94 .053   






t p R2 ∆R2 
Step 1 Model 
(Covariates) 
.12     -.004  





BMI  -.09 -.04 -.81 .42   




 -.12 -.09 -1.34 .18   
DBP Recovery 
(No distraction) 
 -.19 -.08 -1.23 .22   
DV = PCL-M (PTSD) one-year Post Deployment 






t p R2 ∆R2 
Step 1 Model  16.41**     .04**  
DRRI_PDLE  .72 .22 4.05 <.001*
* 
  
Step 2 Model 26.01**      .09** 
DRRI PDLE  .49 .15 2.85 .005*   
DRR DE  .93 .31 5.83 <.001*
* 
  
Step 3 Model 20.06**      .02* 
DRRI PDLE  .44 .13 2.57 .011*   





 -.26 -.15 -2.91 .004**   












t p R2 ∆R2 
Step 1 Model  15.86**     .04**  
DRRI_PDLE  .71 .21 3.98 <.001*
* 
  
Step 2 Model 26.01**      .09** 
DRRI PDLE  .49 .15 2.81 .005*   
DRR DE  .94 .31 5.88 <.001*
* 
  
Step 3 Model 20.06**      .02* 
DRRI PDLE  .47 .14 2.57 .007*   
DRRI DE  .90 .29 5.66 <.001*
* 
  
SBP Reactivity  -.20 -.14 -2.913 .008*   
DV = PCL-M (PTSD) Immediate Post Deployment 






t p R2 ∆R2 
Step 1 Model  19.80**     .06**  







Step 2 Model 37.31**      .13** 
DRRI PDLE  .72 .17 3.26 .001**   
DRR DE  1.34 .37 7.19 <.001*
* 
  
Step 3 Model 28.02**      .02* 
DRRI PDLE  .66 .16 3.02 .003*   
DRRI DE  .84 .23 3.28 .001**   
SBP Reactivity  .38 .20 2.80 .005*   
Step 4 Model 22.56**      .01* 
DRRI PDLE  .65 .15 2.98 .003*   
DRRI DE  .80 .22 3.11 .002*   
DRRI CE  .38 .20 2.81 .005*   
SBP Reactivity  -.21 -.11 -2.26 .03*   
DV = PCL-M (PTSD) one-year Post Deployment 
Summary of Stepwise Regression Analysis: Hypothesis 3 (Recovery without completing 
questionnaires) 





t p R2 ∆R2 
Step 1 Model  19.80**     .06**  
DRRI_PDLE  1.05 .25 4.47 <.001*
* 
  
Step 2 Model 37.31**      .13** 





DRR DE  1.35 .37 7.20 <.001*
* 
  
Step 3 Model 28.02**      .02* 
DRRI PDLE  .68 .16 3.08 .002*   
DRRI DE  .86 .24 3.34 .001**   
SBP Reactivity  .38 .20 2.72 .005*   
Step 4 Model 22.56**      .01* 
DRRI PDLE  .67 .16 3.06 .001**   
DRRI DE  .82 .23 3.18 .002*   
DRRI CE  .38 .20 2.74 .006*   
SBP Reactivity  -.22 -.11 -2.26 .02*   
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